ANIK
Anika Therapeutics Inc
19.10$
-1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -43.9% | -103.5% | – | – | -68.5% | -108.2% | – | – | -32.5% | -204.5% | – | – | |
| – | +1.4% | -42.6% | -0.2% | +6.3% | -17.2% | -12.1% | -11.1% | -0.9% | -6.1% | +6.8% | +7.0% | – | |
| – | +7.1% | -5.9% | +8.4% | -12.8% | -33.6% | +27.0% | -11.0% | -13.1% | +11.0% | +170.2% | -72.4% | – | |
| – | -175.9% | – | – | – | -258.4% | – | – | – | -125.6% | – | – | – | |
| – | +148.3% | -1.7% | +88.2% | -46.6% | -28.0% | +116.1% | -48.1% | +28.6% | -65.7% | +120.8% | +1.3% | – | |
| – | +148.3% | -1.7% | +88.2% | -46.6% | -28.0% | – | -132.2% | +221.3% | – | -725.8% | +3.3% | – | |
| – | – | -32,900.0% | -40.3% | +189.7% | +40.5% | -28.8% | -100.0% | – | +42,315.4% | +57.6% | -90.2% | – | |
| – | – | -764.6% | -51.1% | +259.2% | +34.2% | +1.6% | – | -107.3% | +40,507.7% | +96.0% | -93.2% | – | |
| – | -60.3% | -105.0% | – | – | – | – | – | – | -110.6% | – | – | – | |
| – | -68.7% | -207.6% | – | – | -91.4% | -1,174.2% | – | – | -19.9% | -257.4% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.